AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership1,388 shares
Latest Disclosed Value $ 257,640
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.34% decrease in ownership of ABBV / AbbVie Inc.

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 1,388 shares of AbbVie Inc. (US:ABBV) valued at $257,641 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 1,451 shares of AbbVie Inc.. This represents a change in shares of -4.34% during the quarter. The current value of the position is $312,217 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP AbbVie EC US00287Y1091 1,388 -63 -4.34 258 -15.46 0.3796
2025-05-27 2025-03-31 NP AbbVie EC US00287Y1091 1,451 -48 -3.20 304 14.29 0.4581
2025-02-26 2024-12-31 NP AbbVie EC US00287Y1091 1,499 -96 -6.02 266 -15.29 0.3811
2024-11-25 2024-09-30 NP AbbVie EC US00287Y1091 1,595 -43 -2.63 315 12.14 0.4344
2024-08-26 2024-06-30 NP AbbVie EC US00287Y1091 1,638 -38 -2.27 281 -8.20 0.4025
2024-05-28 2024-03-31 NP AbbVie EC US00287Y1091 1,676 -91 -5.15 305 11.72 0.4375
2024-02-28 2023-12-31 NP AbbVie EC US00287Y1091 1,767 -42 -2.32 274 1.49 0.4106
2023-11-22 2023-09-30 NP AbbVie EC US00287Y1091 1,809 -207 -10.27 270 -0.74 0.4337
2023-08-28 2023-06-30 NP AbbVie EC US00287Y1091 2,016 5 0.25 272 -15.31 0.4097
2023-05-25 2023-03-31 NP AbbVie EC US00287Y1091 2,011 -41 -2.00 320 -3.32 0.4970
2023-02-24 2022-12-31 NP AbbVie EC US00287Y1091 2,052 -37 -1.77 332 18.21 0.5301
2022-11-29 2022-09-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,089 -51 -2.38 280 -14.37 0.4574
2022-08-29 2022-06-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,140 -47 -2.15 328 -7.63 0.4989
2022-05-31 2022-03-31 NP ABBVIE INC USD.01 EC US00287Y1091 2,187 -62 -2.76 355 16.45 0.4640
2022-02-28 2021-12-31 NP ABBVIE INC USD.01 EC US00287Y1091 2,249 -80 -3.43 305 21.12 0.3663
2021-11-24 2021-09-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,329 -99 -4.08 251 -8.06 0.3122
2021-08-27 2021-06-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,428 -132 -5.16 273 -1.44 0.3337
2021-06-01 2021-03-31 NP ABBVIE INC USD.01 EC US00287Y1091 2,560 -144 -5.33 277 -4.15 0.3492
2021-03-01 2020-12-31 NP ABBVIE INC USD.01 EC US00287Y1091 2,704 -166 -5.78 290 15.14 0.3676
2020-11-25 2020-09-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,870 -111 -3.72 251 -14.04 0.3373
2020-08-28 2020-06-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,981 601 25.25 293 61.33 0.4110
2020-05-28 2020-03-31 NP ABBVIE INC USD.01 EC US00287Y1091 2,380 -53 -2.18 181 -15.81 0.2838
2020-02-28 2019-12-31 NP ABBVIE INC USD.01 EC 00287Y109 2,433 -153 -5.92 215 10.26 0.2982
2019-11-26 2019-09-30 NP ABBVIE INC USD.01 EC US00287Y1091 2,586 2,586 196 0.2712
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.